Towards optimizing use of PLA2R antibody testing in membranous nephropathy

J Nephrol. 2021 Apr;34(2):557-559. doi: 10.1007/s40620-021-00971-w.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Autoantibodies
  • Glomerulonephritis, Membranous* / diagnosis
  • Humans
  • Receptors, Phospholipase A2

Substances

  • Autoantibodies
  • Receptors, Phospholipase A2